On November 13, 2009
Sequenom Insider Accused of $366K Stock Sale Before Data Corruption Revealed
Steven Owings, the former vp commercial development at Sequenom (SQNM), sold 22,598 shares for a total of $365,967, on March 24, 2009, a month before the company revealed that all its data for its T21/SEQureDx Down Syndrome test was corrupted by “employee mishandling,” according to a lawsuit filed in California federal court.
0 Comments